Previous Close | 33.21 |
Open | 33.53 |
Bid | 13.37 x 1000 |
Ask | 0.00 x 800 |
Day's Range | 33.20 - 33.68 |
52 Week Range | 24.84 - 35.29 |
Volume | |
Avg. Volume | 679,173 |
Market Cap | 5.036B |
Beta (5Y Monthly) | 1.09 |
PE Ratio (TTM) | 28.56 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.14 (3.41%) |
Ex-Dividend Date | Mar 13, 2024 |
1y Target Est | N/A |
A solid timberland portfolio and developments in biogenetics and cloning are likely to aid Rayonier (RYN).
Third Avenue Management, an investment management company based in New York City, released its “Third Avenue Real Estate Value Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. In the calendar year, the fund returned +23.27% (after fees) versus +10.85% for the Fund’s most relevant benchmark, the FTSE EPRA […]
Rayonier Inc. (NYSE:RYN) Q4 2023 Earnings Call Transcript February 1, 2024 Rayonier Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome, and thank you for joining Rayonier’s Fourth Quarter and Full Year Teleconference Call. [Operator Instructions] Today’s conference is […]